Entrepreneurs against cancer

Aniling @ ViaEmpresa: 36% of R&D in the biomedical sector is used for oncology, a field that seeks the ultimate therapy to eliminate the disease and that demands new services …

ANILING engagement in the AMMIC project

ANILING takes part in the collaborative project AMMIC (standing for Accelerator in Rare Diseases of Catalonia for its initials in Catalan), in which VHIR and companies like Aromics and Qgenomics …